Inhibikase Therapeutics, Inc.
IKT
$2.37
$0.010.42%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -59.15% | -18.56% | -26.43% | -21.27% | -19.60% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -22.81% | -59.87% | 15.67% | 106.12% | -33.22% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 108.42% | 42.56% | -5.07% | -34.30% | -17.24% |
| Total Current Assets | -51.29% | -20.40% | -23.95% | -19.03% | -20.17% |
|
|
|||||
| Total Current Assets | -51.29% | -20.40% | -23.95% | -19.03% | -20.17% |
| Net Property, Plant & Equipment | -16.61% | -13.95% | -11.94% | -10.42% | -9.24% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -50.41% | -20.25% | -23.70% | -18.87% | -19.99% |
|
|
|||||
| Total Accounts Payable | 88.68% | 3.61% | 100.03% | -11.95% | -2.59% |
| Total Accrued Expenses | 6.24% | -18.87% | 10.96% | 21.62% | 1.49% |
| Short-term Debt | -59.56% | -36.81% | -26.51% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -4.60% | 0.66% | 0.73% | 0.74% | 0.68% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 32.47% | -12.49% | 23.11% | 25.41% | 0.32% |
|
|
|||||
| Total Current Liabilities | 32.47% | -12.49% | 23.11% | 25.41% | 0.32% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -59.56% | -36.81% | -26.51% | -- | -- |
| Capital Leases | -- | -56.09% | -35.29% | -25.54% | -19.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 31.56% | -13.08% | 21.61% | 23.26% | -0.70% |
|
|
|||||
| Common Stock & APIC | 0.18% | 4.19% | 0.58% | 0.18% | 0.19% |
| Retained Earnings | -7.55% | -6.93% | -6.95% | -6.66% | -7.91% |
| Treasury Stock & Other | 280.00% | 44.44% | -300.00% | 1,000.00% | 94.12% |
| Total Common Equity | -110.41% | -24.79% | -38.27% | -26.90% | -22.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -110.41% | -24.79% | -38.27% | -26.90% | -22.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -110.41% | -24.79% | -38.27% | -26.90% | -22.84% |
|
|
|||||
